Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Home > Cartherics News > Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Karen Loudon2019-01-23T23:36:03+11:00January 23rd, 2019|

Cartherics-led Consortium Receives $5.4M Federal Funding for Cellular Immunotherapy Research into Ovarian and Gastric Cancers

September 30, 2022

MELBOURNE, Australia, 27 September 2022 – Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, together...

General The Pipeline

3 Cheers for a Cartherics Board Member

June 16, 2022

Bryan Williams ranked among the world’s most prominent scientists By Leigh Dayton, 16 June 2022 Cartherics is delighted to announce...

General The Pipeline

She’s an Adventurer, Advocate, Author and a Cancer Survivor

June 9, 2022

Now Heather Hawkins is a member of the Cartherics Board By Leigh Dayton 9 June 2022 It’s official. As of...

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Share This Post